EX-10.1
from 8-K
103 pages
Credit Agreement and Guaranty Dated as of February 10, 2020 Among Agile Therapeutics, Inc., as the Borrower, the Guarantors From Time to Time Party Hereto, as Guarantors the Lenders From Time to Time Party Hereto, as Lenders and Perceptive Credit Holdings III, LP and Its Successors and Assigns Party Hereto, as Administrative Agent and as a Lender $35,000,000
12/34/56
EX-10.2
from 8-K
3 pages
For Good and Valuable Consideration, the Receipt and Sufficiency of Which Are Hereby Acknowledged by Agile Therapeutics, Inc., a Delaware Corporation (The “Company”), the Company Hereby Grants to Hercules Technology Growth Capital, Inc., a Maryland Corporation, in Its Capacity Under and Pursuant to the Loan Agreement (As Defined Below) as Administrative Agent for Itself and the Lender (As Defined in the Loan Agreement) (“Hercules”), the Right to Participate in and/or Designate One or More of Its Affiliates (Hercules, Together With Such Affiliates, Collectively, “Hercules Purchasers”) to Participate in Any One or More Subsequent Financings (As Defined Below) Selected by Hercules in Its Sole Discretion by Permitting All Hercules Purchasers Who Participate in Such Subsequent Financings to Purchase Up to a Maximum Aggregate (For All Subsequent Financings) of $2,000,000.00 of Subsequent Financing Securities (As Defined Below) Therein. Hercules Purchasers Shall Have No Obligation to Purchase Subsequent Financing Securities. Each Hercules Purchaser Acquiring Subsequent Financing Securities in a Subsequent Financing Shall Be an “Accredited Investor” as Defined in Regulation D Promulgated Under the Securities Act of 1933, as Amended (The “Act”). as Used Herein
12/34/56
